As of March 23, 2026, Allarity Therapeutics's top three insider holders are Thomas Jensen (Ceo, 396.73K shares), Jeremy R. Graff (See Remarks, 381.64K shares), Alexander Epshinsky (Cfo, 85.05K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Thomas Jensen | Ceo | 396,734 | 0 | 24 Jan, 2025 |
| Alexander Epshinsky | Cfo | 85,051 | 0 | 24 Jan, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 22 Jan, 2025 | Joseph Walter Vazzano | Stock Options | A | 25,000 | $0.00 | 25,000 | D | A |
| 22 Jan, 2025 | Thomas Jensen | Common Stock | A | 396,734 | $0.00 | 396,734 | D | A |
| 22 Jan, 2025 | Alexander Epshinsky | Common Stock | A | 29,496 | $0.00 | 85,051 | D | A |
| 22 Jan, 2025 | Laura Benjamin | Stock Options | A | 25,000 | $0.00 | 25,000 | D | A |
| 22 Jan, 2025 | Laura Benjamin | Stock Options | A | 25,000 | $0.00 | 25,000 | D | A |
| 22 Jan, 2025 | Joseph Walter Vazzano | Stock Options | A | 25,000 | $0.00 | 25,000 | D | A |